Development Level

Tbio 49 | 10,625
Tchem 7 | 1,890
Tdark 3 | 7,003

IMPC Term

decreased body length 2 | 108
decreased lean body mass 2 | 195
improved glucose tolerance 2 | 56
preweaning lethality, complete... 2 | 633
preweaning lethality, incomple... 2 | 260
abnormal bone structure 1 | 131
abnormal femur morphology 1 | 14
abnormal kidney morphology 1 | 30
abnormal respiratory quotient 1 | 9
abnormal rib morphology 1 | 28
abnormal thoracic vertebrae mo... 1 | 16
abnormal vibrissa morphology 1 | 17
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating alkaline... 1 | 41
decreased circulating aspartat... 1 | 27
decreased circulating choleste... 1 | 85
decreased circulating fructosa... 1 | 31
decreased circulating glucose ... 1 | 121
decreased circulating insulin ... 1 | 75
decreased circulating potassiu... 1 | 17
decreased circulating total pr... 1 | 41
decreased heart weight 1 | 44
decreased lactate dehydrogenas... 1 | 14
decreased lumbar vertebrae num... 1 | 62
decreased memory-marker CD4-ne... 1 | 4
decreased rib number 1 | 59
decreased total body fat amoun... 1 | 186
dilated heart left ventricle 1 | 10
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
fusion of vertebral arches 1 | 7
hyperactivity 1 | 108
immune system phenotype 1 | 17
impaired glucose tolerance 1 | 52
increased CD4-negative NK T ce... 1 | 4
increased bone mineral content 1 | 92
increased bone mineral density 1 | 52
increased grip strength 1 | 83
increased sacral vertebrae num... 1 | 62
male infertility 1 | 62
vertebral fusion 1 | 23
vertebral transformation 1 | 12

Disease

ovarian cancer 31 | 8,484
lung cancer 27 | 4,466
osteosarcoma 27 | 7,933
glioblastoma 26 | 5,572
psoriasis 23 | 6,685
atypical teratoid / rhabdoid tumor 20 | 4,369
malignant mesothelioma 20 | 3,162
medulloblastoma, large-cell 19 | 6,234
pilocytic astrocytoma 16 | 3,086
non-small cell lung cancer 15 | 2,798
oligodendroglioma 15 | 2,849
Cancer 14 | 2,346
pediatric high grade glioma 14 | 2,712
lung carcinoma 13 | 2,844
pituitary cancer 13 | 1,972
Breast cancer 12 | 3,094
Carcinoma 12 | 2,147
cystic fibrosis 12 | 1,665
invasive ductal carcinoma 12 | 2,950
primitive neuroectodermal tumor 12 | 3,031
ulcerative colitis 12 | 2,087
Pick disease 11 | 1,893
adult high grade glioma 11 | 2,148
intraductal papillary-mucinous adenoma (IPMA) 11 | 2,956
lung adenocarcinoma 11 | 2,713
pancreatic cancer 11 | 2,300
subependymal giant cell astrocytoma 11 | 2,287
colon cancer 10 | 1,475
intraductal papillary-mucinous carcinoma (IPMC) 10 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
ductal carcinoma in situ 9 | 1,745
ependymoma 9 | 2,514
esophageal adenocarcinoma 9 | 737
interstitial cystitis 9 | 2,299
spina bifida 9 | 1,064
astrocytic glioma 8 | 2,241
astrocytoma 8 | 1,493
breast carcinoma 8 | 1,614
cutaneous lupus erythematosus 8 | 1,056
group 4 medulloblastoma 8 | 1,875
medulloblastoma 8 | 1,524
posterior fossa group A ependymoma 8 | 1,511
adrenocortical carcinoma 7 | 1,427
dermatomyositis 7 | 933
primary pancreatic ductal adenocarcinoma 7 | 1,271
tuberculosis 6 | 1,557
Alzheimer's disease 5 | 644
Amyotrophic Lateral Sclerosis 5 | 431
Down syndrome 5 | 548
acute myeloid leukemia 5 | 780
acute quadriplegic myopathy 5 | 1,157
diabetes mellitus 5 | 1,663
gastric carcinoma 5 | 832
juvenile dermatomyositis 5 | 1,189
nasopharyngeal carcinoma 5 | 1,056
primary Sjogren syndrome 5 | 789
sonic hedgehog group medulloblastoma 5 | 1,482
tuberculosis and treatment for 6 months 5 | 686
Atopic dermatitis 4 | 944
Cardiovascular system disease 4 | 194
Duchenne muscular dystrophy 4 | 602
Heart disease 4 | 279
Multiple Sclerosis 4 | 498
Neurodegenerative disease 4 | 383
Rheumatoid Arthritis 4 | 1,160
Squamous cell carcinoma 4 | 94
Waldenstrons macroglobulinemia 4 | 765
active Crohn's disease 4 | 918
atypical teratoid/rhabdoid tumor 4 | 1,095
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 499
non primary Sjogren syndrome sicca 4 | 840
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,795
Cataract 3 | 104
Cleft palate 3 | 125
Craniofacial Abnormalities 3 | 147
Epidermolytic hyperkeratosis 3 | 13
Intellectual disability 3 | 573
Keratosis 3 | 34
Long QT syndrome 3 | 52
Myopia 3 | 99
aldosterone-producing adenoma 3 | 664
head and neck cancer 3 | 270
interstitial lung disease 3 | 291
nephrosclerosis 3 | 329
posterior fossa group B ependymoma 3 | 1,530
sarcoidosis 3 | 358
Becker muscular dystrophy 2 | 187
Chronic obstructive pulmonary disease 2 | 146
Disease Progression 2 | 125
Fibrochondrogenesis 2 | 8
Glaucoma 2 | 134
Neuropathy 2 | 210
Prostatic Neoplasms 2 | 471
Schizophrenia 2 | 501
Spontaneous abortion 2 | 108
chronic lymphosyte leukemia 2 | 232
fibroadenoma 2 | 557
hereditary spastic paraplegia 2 | 313
limb girdle muscular dystrophy 2A 2 | 156
severe Alzheimer's disease 2 | 49

Tissue

Blood and immune system 59 | 17,995
Cardiovascular System 59 | 17,958
Digestive Tract 59 | 18,473
Endocrine System 59 | 18,512
Female tissues 59 | 18,647
Liver and Pancreas 59 | 18,136
Male tissues 59 | 17,969
Nervous System 59 | 18,561
Respiratory system 59 | 17,484
Urinary Tract 59 | 18,444
Skin and soft tissues 58 | 18,115

Target Family

Non-IDG 48 | 11,971
Enzyme 9 | 4,146
Epigenetic 1 | 242
Transporter 1 | 473

GO Function

protein binding, bridging 59 | 59
metal ion binding 1,917 | 1,917
ATP binding 1,467 | 1,467
DNA binding 1,432 | 1,432
zinc ion binding 1,155 | 1,155
poly(A) RNA binding 1,107 | 1,107
transcription factor activity,... 853 | 853
calcium ion binding 695 | 695
G-protein coupled receptor act... 661 | 661
protein homodimerization activ... 569 | 569
RNA binding 445 | 445
olfactory receptor activity 424 | 424
sequence-specific DNA binding 398 | 398
GTP binding 374 | 374
chromatin binding 372 | 372
protein serine/threonine kinas... 336 | 336
RNA polymerase II core promote... 332 | 332
identical protein binding 311 | 311
nucleotide binding 311 | 311
receptor binding 303 | 303
protein kinase binding 289 | 289
enzyme binding 286 | 286
cadherin binding involved in c... 277 | 277
GTPase activator activity 273 | 273
ubiquitin protein ligase bindi... 258 | 258
ubiquitin-protein transferase ... 253 | 253
serine-type endopeptidase acti... 246 | 246
transcription coactivator acti... 241 | 241
transcription factor binding 240 | 240
structural molecule activity 232 | 232
GTPase activity 231 | 231
transcriptional activator acti... 230 | 230
ligase activity 227 | 227
protein heterodimerization act... 227 | 227
structural constituent of ribo... 212 | 212
transcription regulatory regio... 202 | 202
transmembrane signaling recept... 201 | 201
RNA polymerase II regulatory r... 200 | 200
receptor activity 200 | 200
transcription corepressor acti... 198 | 198
magnesium ion binding 197 | 197
signal transducer activity 196 | 196
nucleic acid binding 184 | 184
protein kinase activity 183 | 183
carbohydrate binding 180 | 180
ubiquitin protein ligase activ... 173 | 173
RNA polymerase II transcriptio... 162 | 162
heparin binding 160 | 160
iron ion binding 141 | 141
lipid binding 136 | 136
transporter activity 136 | 136
actin binding 133 | 133
ATPase activity 132 | 132
protein C-terminus binding 129 | 129
heme binding 127 | 127
microtubule binding 123 | 123
protein tyrosine kinase activi... 119 | 119
cytokine activity 118 | 118
Ras guanyl-nucleotide exchange... 113 | 113
mRNA binding 112 | 112
metalloendopeptidase activity 112 | 112
transcriptional repressor acti... 110 | 110
structural constituent of cyto... 108 | 108
Rab GTPase binding 105 | 105
antigen binding 104 | 104
protein domain specific bindin... 102 | 102
peptide antigen binding 101 | 101
guanyl-nucleotide exchange fac... 98 | 98
protein complex binding 96 | 96
serine-type endopeptidase inhi... 96 | 96
odorant binding 92 | 92
oxidoreductase activity 91 | 91
transcriptional activator acti... 91 | 91
actin filament binding 89 | 89
hydrolase activity 89 | 89
ion channel binding 89 | 89
protein tyrosine phosphatase a... 88 | 88
electron carrier activity 87 | 87
protease binding 87 | 87
histone binding 86 | 86
integrin binding 83 | 83
growth factor activity 82 | 82
phospholipid binding 82 | 82
single-stranded DNA binding 81 | 81
unfolded protein binding 77 | 77
kinase activity 75 | 75
thiol-dependent ubiquitin-spec... 75 | 75
phosphatidylinositol binding 74 | 74
calmodulin binding 73 | 73
histone deacetylase binding 73 | 73
Rho guanyl-nucleotide exchange... 72 | 72
drug binding 71 | 71
double-stranded DNA binding 70 | 70
peptidase activity 70 | 70
protein N-terminus binding 70 | 70
virus receptor activity 68 | 68
beta-catenin binding 67 | 67
microtubule motor activity 67 | 67
protein transporter activity 67 | 67
calcium channel activity 66 | 66
ubiquitin binding 66 | 66

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Neurofilament heavy polypeptide NEFH Tbio Non-IDG -2.73883 563.3 681
Desmoplakin DSP Tbio Non-IDG -2.90088 786.5 167
Transcriptional repressor p66-alpha GATAD2A Tbio Non-IDG -0.79314 7.11 142
Collagen alpha-1(XI) chain COL11A1 Tbio Non-IDG -2.09756 129.5 88
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha PPP2R3A Tbio Enzyme -1.19072 14.4 144
Cornifin-A SPRR1A Tbio Non-IDG -1.15694 13.4 60
Collagen alpha-2(XI) chain COL11A2 Tchem Non-IDG -1.86796 68.8 95
Telethonin TCAP Tbio Non-IDG -3.27036 1924.4 78
E3 ubiquitin-protein ligase TRIM22 TRIM22 Tbio Enzyme -1.46578 40.5 140
Hsc70-interacting protein ST13 Tbio Non-IDG 75.6 218